Filing Flows › Iradimed (IRMD) › Q1 2026
Iradimed (IRMD) Q1 2026 earnings results (first quarter 2026)
10-Q filed May 1, 2026
Iradimed (IRMD) reported revenue of $22.0M for the first quarter 2026 (Q1 2026), +13% from a year earlier and -3% from the quarter before. Operating margin was 32.9%, net earnings $5.8M (26.5% of revenue).
Iradimed, Q1 2026: revenue $22.0M (+13% year over year), operating margin 32.9%, net earnings $5.8M, operating cash flow $8.3M. The chart follows the revenue to costs, profit and cash.
| Q1 2026 | Amount | Q/Q | Y/Y |
|---|---|---|---|
| Revenue | $22.0M | -3% | +13% |
| Gross profit | $16.8M | -1% | +13% |
| Operating profit | $7.2M | +2% | +33% |
| Net earnings | $5.8M | -10% | +24% |
| Operating cash flow | $8.3M | +40% | +93% |
| Free cash flow | $7.8M | — | 21× |
What changed
Revenue was $22.0M in Q1 2026, up 13% year over year and down 3% from the previous quarter. MRI Compatible IV Infusion Pumps was the largest line at 35% of revenue. MRI Compatible IV Infusion Pumps added $1.7M year over year (up 28%), 67% of the total change. Disposables declined 1%.
Gross margin was 76.5%, up 0.4 points from Q1 2025. Operating profit was $7.2M, a 32.9% margin (up 5.1 points year over year). Of the extra revenue versus Q1 2025, 73% reached operating profit, above the 28% margin then. Operating expenses grew 2% against revenue growth of 13%. The fastest-growing cost line was Research & development (+53%). Net earnings were $5.8M, up 24% year over year. The effective tax rate was 25.1%.
Operating cash flow was $8.3M (up 93% year over year), 142% of net earnings. Non-cash charges added back $455K of depreciation and amortization and $684K of share-based compensation. Working capital and other items added $1.3M. After capital Expenditures ($469K), free cash flow as the company reports it was $7.8M.
Questions
What was Iradimed's revenue in the first quarter 2026?
Iradimed (IRMD) reported revenue of $22.0M for the first quarter 2026 (Q1 2026), +13% from a year earlier and -3% from the quarter before.
Was Iradimed profitable in the first quarter 2026?
Operating profit was $7.2M (32.9% of revenue) and net earnings $5.8M.
Source: Iradimed 10-Q on SEC EDGAR.